# Antiarrhythmics Versus Implantable Defibrillators (AVID)

> **NCT00000531** · PHASE3 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)**

## Conditions studied

- Arrhythmia
- Cardiovascular Diseases
- Death, Sudden, Cardiac
- Heart Diseases
- Tachycardia, Ventricular
- Ventricular Fibrillation

## Interventions

- **DEVICE:** defibrillators, implantable
- **DRUG:** amiodarone amiodarone
- **DRUG:** sotalol

## Key facts

- **NCT ID:** NCT00000531
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1992-09
- **Primary completion:** —
- **Final completion:** 2002-08
- **Target enrollment:** — (—)
- **Last updated:** 2016-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000531, "Antiarrhythmics Versus Implantable Defibrillators (AVID)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00000531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*